Capitalizing on the proliferation of lawsuits over intellectual property, a new litigation financing company is offering patent attorneys and hopeful patent-holding plaintiffs up to $10 million in loans to supercharge their cases in court.
With nearly one million patent applications pending at the U.S. Patent and Trademark Office, the agency appears unable to keep up with steadily increasing demand and patent complexity, causing its leaders to concede some long-term goals may have been too ambitious.
Generic drug maker Mylan Pharmaceuticals Inc. failed to show the active ingredients in its version of epilepsy drug Depakote are identical to Abbott Laboratories’ original version as required by U.S. Code, according to a federal patent infringement lawsuit filed by Abbott recently.
Robins, Kaplan, Miller & Ciresi has hired Sue Halverson, a former counsel for medical device maker Medtronic, as of counsel in the firm’s intellectual property litigation and mass tort practices.
A jury has ruled in favor of Monsanto Co. in the company’s patent dispute with rival Bayer CropScience over an insect-protection technology for corn.
General Motors Corp. has inflated its annual revenue by as much as $400 million since 2001, according to a new securities fraud class action lawsuit filed Monday, the same day the automaker announced 30,000 layoffs in its U.S. plants.
A patent attorney's invention that was purchased by a holding company and asserted against Amazon has been rejected by the Federal Circuit as invalid.
Shareholders in securities class action lawsuits against bankrupt auto parts manufacturer Delphi Corp. are seeking an exemption from bankruptcy laws to force the company to hand over documents considered vital to the plaintiffs.
Some of the biggest names in electronics, including DirecTV, Echostar, Mitsubishi, JVC, Pioneer, and Sony, have been slapped with a lawsuit by a tiny Illinois company that alleges the technology giants infringed its patent for digital set-top box satellite receivers.
A federal judge has granted Abbott Laboratories Inc.’s request for a preliminary injunction against Ranbaxy Laboratories Ltd. and Andrx Corp. over its antibiotic Biaxin XL.
Two contentious lawsuits over Trading Technologies’ heavily asserted patents for futures trading software face an uncertain outcome after bankrupt defendant Refco LLC was purchased at auction Wednesday by another defendant, Man Group PLC.
A three-judge panel of the Indiana Court of Appeals on Tuesday unanimously upheld a lower court's ruling ordering Conseco Inc. founder Stephen Hilbert to pay $72 million to his former company.
Auto parts maker Dana Corporation said it would not restate its earnings for the past two years in its third-quarter report, an announcement that is likely to prompt several more class action lawsuits against the troubled company.
A district court will no longer need to weigh in on who has the rights to the letter Q, as automakers Nissan and Audi have settled their trademark dispute over the letter out of court.
The U.S. patent regime stands on the threshold of the most sweeping reforms in decades, intellectual property attorneys agree. But in a twist, the most dramatic changes will likely come not from Congress, but from the Supreme Court, where a buffet of patent lawsuits awaits consideration for appeal.
Apple Inc.’s iPod personal music players, including the popular new “nano” and “mini” versions, infringe the patented technology of a small Illinois patent holding company, according to a federal lawsuit.
The U.K. House of Lords has upheld a lower court’s decision to invalidate the patent for the key ingredient in GlaxoSmithKline’s Paxil, one of the world’s most widely prescribed antidepressants.
Patent attorneys are crying foul as bankrupt commodities broker Refco Inc.’s intellectual property is readied for the auction block, claiming infringing technology is not part of an estate and therefore cannot be sold under bankruptcy law.
The U.S. Securities and Exchange Commission suffered defeat in court Monday, when a federal judge ordered the agency to hand over to a research firm information on investigations it had sought to withhold.
Microsoft was dealt a major blow by the U.S. Supreme Court Monday in its patent infringement defense against Eolas Technologies Inc. The high court declined to hear the computer giant’s appeal, pushing it closer to having to pay a $561 million judgment levied by a lower court.